LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder.

MLA

Bidwell, L.Cinnamon, et al. “LOTUS: Protocol for a Double-Blind Placebo Controlled Randomized Trial of Hemp-Derived Cannabidiol for the Treatment of Cannabis Use Disorder.” PLoS ONE, vol. 19, no. 9, Sept. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1371/journal.pone.0308262.

APA

Bidwell, L. C., Martin-Willett, R., Melendez, S. N., Rosa, L., Giordano, G., Hutchison, K. E., & Bryan, A. D. (2024). LOTUS: Protocol for a double-blind placebo controlled randomized trial of hemp-derived cannabidiol for the treatment of cannabis use disorder. PLoS ONE, 19(9), 1–14. https://doi.org/10.1371/journal.pone.0308262

Chicago

Bidwell, L. Cinnamon, Renee Martin-Willett, Samantha N. Melendez, Luiza Rosa, Gregory Giordano, Kent E. Hutchison, and Angela D. Bryan. 2024. “LOTUS: Protocol for a Double-Blind Placebo Controlled Randomized Trial of Hemp-Derived Cannabidiol for the Treatment of Cannabis Use Disorder.” PLoS ONE 19 (9): 1–14. doi:10.1371/journal.pone.0308262.